You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glucophage Extended Release

Showing 1 - 25 of 8,420
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tendinopathy, Chronic Pain, Achilles Tendinopathy Trial in Pittsburgh (Metformin, Placebo)

Not yet recruiting
  • Tendinopathy
  • +2 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh
Oct 19, 2023

Lung Carcinoma Trial in Aurora, Buffalo, Vancouver (Extended Release Metformin Hydrochloride)

Recruiting
  • Lung Carcinoma
  • Biopsy
  • +4 more
  • Aurora, Colorado
  • +2 more
Jan 28, 2023

Low Back Pain Trial in Pittsburgh, Wexford (Metformin, Placebo)

Active, not recruiting
  • Low Back Pain
  • Pittsburgh, Pennsylvania
  • +1 more
Oct 28, 2022

Aging, Insulin Sensitivity, Chronic Disease Trial in Oklahoma City, Madison (Metformin, Placebo oral tablet)

Recruiting
  • Aging
  • +4 more
  • Oklahoma City, Oklahoma
  • +1 more
Nov 16, 2021

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Breast Ductal Carcinoma In Situ Trial in

Not yet recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +3 more
  • Biospecimen Collection
  • +4 more
  • Houston, Texas
  • +2 more
Aug 17, 2022

Erythroplakia, Oral Leukoplakia Trial in Canada, United States (Extended Release Metformin Hydrochloride, Placebo

Not yet recruiting
  • Erythroplakia
  • Oral Leukoplakia
  • Biopsy
  • +3 more
  • Tucson, Arizona
  • +9 more
Dec 14, 2022

Plasminogen Activator Inhibitor-1 Deficiency, Cardiac Fibrosis Trial (Metformin Extended Release Oral Tablet)

Not yet recruiting
  • Plasminogen Activator Inhibitor-1 Deficiency
  • Cardiac Fibrosis
  • Metformin Extended Release Oral Tablet
  • (no location specified)
Aug 1, 2022

Prostate Cancer, Prostate Cancer Recurrent Trial in Mineola (Metformin Hydrochloride Extended Release 750mg)

Completed
  • Prostate Cancer
  • Prostate Cancer Recurrent
  • Metformin Hydrochloride Extended Release 750mg
  • Mineola, New York
    Winthrop University Hospital
Feb 2, 2022

Head and Neck Squamous Cell Carcinoma Trial in Cincinnati (Metformin Extended Release Oral Tablet, Pembrolizumab)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Cincinnati, Ohio
    University of Cincinnati Medical Center
Sep 15, 2021

Cannabis Use Disorder Trial in Parkville (Guanfacine Extended Release Oral Tablet, Residential withdrawal, Engagement with

Not yet recruiting
  • Cannabis Use Disorder
  • Guanfacine Extended Release Oral Tablet
  • +3 more
  • Parkville, Victoria, Australia
    Orygen
Jul 16, 2023

Atopic Dermatitis Trial in Hangzhou (TLL-018 extended-release tablet, TLL-018 immediate-release tablet)

Active, not recruiting
  • Atopic Dermatitis
  • TLL-018 extended-release tablet
  • TLL-018 immediate-release tablet
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital Zhejiang University School of Med
Jul 12, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 50/500 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza Garcia (Sitagliptin/Metformin HCl 50/500 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
  • San Pedro Garza Garcia, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Narcolepsy Type 1, Narcolepsy With Cataplexy Trial (NLS-2, Placebo)

Not yet recruiting
  • Narcolepsy Type 1
  • Narcolepsy With Cataplexy
  • (no location specified)
Jun 21, 2023

Healthy Trial in Beijing (Test GXR, Reference GXR)

Completed
Has Results
  • Healthy
  • Test GXR
  • Reference GXR
  • Beijing, China
    Xuanwu Hospital Capital Medical University
Dec 18, 2019

Opioid Use Disorder Trial (Buprenorphine Extended-Release Injection)

Not yet recruiting
  • Opioid Use Disorder
  • Buprenorphine Extended-Release Injection
  • (no location specified)
Feb 2, 2023

Cocaine Use Disorder Trial (Extended-Release Naltrexone, Extended Release Buprenorphine, Placebo (PLB) Injectable)

Not yet recruiting
  • Cocaine Use Disorder
  • Extended-Release Naltrexone
  • +2 more
  • (no location specified)
Jul 15, 2022

Advanced Cancer Trial in Taichung, Tainan (CVM-1118 Extended-Release (ER) Capsules (200 mg/capsule))

Completed
  • Advanced Cancer
  • CVM-1118 Extended-Release (ER) Capsules (200 mg/capsule)
  • Taichung, Taiwan
  • +1 more
Nov 25, 2022

End Stage Renal Disease, Rejection of Renal Transplant Trial in Chicago (Tacrolimus, Tacrolimus Extended Release Oral Tablet

Completed
  • End Stage Renal Disease
  • Rejection of Renal Transplant
  • Tacrolimus
  • Tacrolimus Extended Release Oral Tablet [Envarsus]
  • Chicago, Illinois
    Northwestern University
Jan 12, 2023

Somatic Symptom Trial in Shanghai (toludesvenlafaxine HCl sustained-release tablets)

Not yet recruiting
  • Somatic Symptom
  • toludesvenlafaxine hydrochloride sustained-release tablets
  • Shanghai, Shanghai, China
    Shanghai Mental Health Center
May 6, 2023

Epilepsy Trial in Wuhan (Lacosamide Tablets, Lacosamide extended release tablets)

Not yet recruiting
  • Epilepsy
  • Lacosamide Tablets
  • Lacosamide extended release tablets
  • Wuhan, Hubei, China
    Union Hospital of Tongji Medical College of Huazhong University
Mar 15, 2023

Opioid Use Disorder Trial in New York (Extended-Release Buprenorphine (XRB), Sublingual Buprenorphine (SLB))

Not yet recruiting
  • Opioid Use Disorder
  • Extended-Release Buprenorphine (XRB)
  • Sublingual Buprenorphine (SLB)
  • New York, New York
    NYU Langone Health - 180 Madison Ave
Sep 18, 2023

Healthy Trial in Lenexa, Salt Lake City, Groningen (RPV LA, CAB LA)

Recruiting
  • Healthy
  • RPV LA
  • CAB LA
  • Lenexa, Kansas
  • +2 more
Jan 17, 2023